Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Short term Debt (2023 - 2024)

Historic Short term Debt for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Q4 2024 value amounting to $2.8 million.

  • Tonix Pharmaceuticals Holding's Short term Debt rose 2000.0% to $2.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year increase of 2000.0%. This contributed to the annual value of $2.8 million for FY2024, which is 2000.0% up from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Short term Debt of $2.8 million as of Q4 2024, which was up 2000.0% from $2.8 million recorded in Q3 2024.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Short term Debt ranged from a high of $2.8 million in Q1 2024 and a low of $2.4 million during Q4 2023